VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten

Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to

Related Keywords

Synimmune Gmb ,Christoph Antz ,Oliverr Baumann ,Xlife Sciences ,Synimmune Gmbh ,Acute Myeloid Leukemia ,Acute Myeloid ,Shareholders Meeting ,Year Report ,Ouxlife ,Ciences ,Mergers ,Mp ,Cquisitionstakeover ,Eraxa ,Biotech ,Cquires ,Ynimmune ,Xpand ,Dancer ,Pipeline ,Etcest ,Release ,Announcement ,Ursuant ,Ssuer ,Olely ,Esponsible ,Content , ,